STEPHEN FRELLY: Open Payments
NPI 1114966959 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 34 payments from 7 companies in 2025. Trend: 2023 $1,114 · 2024 $2,539 · 2025 $1,255
Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $424 |
| ABBVIE INC. | 15 | $317 |
| Novartis Pharmaceuticals Corporation | 7 | $263 |
| Arcutis Biotherapeutics, Inc. | 3 | $173 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| LEO Pharma Inc. | 1 | $14 |
| Organon LLC | 1 | $7 |
Products named: TREMFYA, RINVOQ, Rhapsido, SKYRIZI, DUPIXENT, Zoryve, ANZUPGO, VTAMA.
Industry payments across ID — which companies pay providers there.
